Navigation Links
Genomic Health to Present at JMP Securities Research Conference
Date:5/13/2009

REDWOOD CITY, Calif., May 13 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Brad Cole, Genomic Health's Chief Operating and Financial Officer, will present at the Eighth Annual JMP Securities Research Conference in San Francisco, on Tuesday, May 19, 2009 at 11:00 a.m. PT.

To access the live and subsequently archived webcast of the presentation, visit the Investor Relations section of Genomic Health's website at http://investor.genomichealth.com. Please connect to the website at least 15 minutes prior to the beginning of the presentation to allow for any necessary software downloads. An archived replay will be available for three months beginning 24 hours after the live presentation.

About Genomic Health

Genomic Health, Inc. (Nasdaq: GHDX) is a life science company focused on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test, Oncotype DX(R), which has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in early-stage breast cancer. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit http://www.genomichealth.com.


'/>"/>
SOURCE Genomic Health, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Video: Turning Hope Into Reality - Genomics Research at the VA
2. Genomic Health to Announce First Quarter 2009 Financial Results and Host Conference Call on Tuesday, May 5, 2009
3. The Personal Genome Project Deploys Isilon IQ Storage to Transform Genomic Research
4. NeoGenomics, Inc. Reports First Quarter 2009 Financial Results
5. NeoGenomics Schedules its Q1 2009 Earnings Release for April 23, 2009
6. Genomic Health Announces Study Confirming Prognostic Value of Oncotype DX(R) Recurrence Score(R) Result in Japanese Breast Cancer Patients
7. El Camino Hospital Launches Genomic Medicine Institute
8. NeoGenomics Appoints Douglas M. VanOort as Executive Chairman and Interim Chief Executive Officer
9. New genomic markers associated with risk of heart disease and early heart attack
10. NeoGenomics to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference
11. Van Andel Research Institute of Michigan and Translational Genomics Research Institute of Arizona Undertake Unprecedented Alliance to Promote Science and Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 23, 2017 , ... The TouchPoint Solution, parent company ... metrics into the product’s app. The data replicates and validates Co-Founder and ... just 30 seconds of using Buzzies, people experienced a 74 percent reduction in ...
(Date:1/23/2017)... ... 2017 , ... PKF O’Connor Davies , LLP, the nation’s 26th largest ... the Firm, will participate in the 40th Annual "Empire State Building Run Up" on ... 1,576 steps, a vertical distance equal to about a fifth of a mile, to ...
(Date:1/23/2017)... ... 2017 , ... Wooden and plastic balance boards have been around since at least the 1950s ... is the first and only balance board to use a patent-pending design featuring high-pressure ... the same time as well as skill-level adjustable for all ages and abilities. The ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... paper on Crystallization in Process Chemistry by Applying Simple PAT Tools . ... organic compounds to isolate and purify the desired product. Chemists now spend ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... the American Society of Anesthesiologists® (ASA®), the Foundation for Anesthesia Education and ... Orthopaedic Surgeons (AAOS) and the Cigna Foundation, encourages proposals supporting high quality ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... GREENWICH, Connecticut , January 24, 2017 ... Gemeinschaftsprojekts mit dem Molecular Surgical Laboratory des Massachusetts General ... angekündigt. Dabei geht es um die Identifizierung und ... von innovativen Ansätzen, dass sie der Resistenz von Antibiotika ... ...
(Date:1/24/2017)... 23, 2017 Optoelectronic components have the ... The interaction of these components with light makes ... range of applications. These components are primarily used ... and healthcare among others. Growing application ... low power consumption, reliability, scalability, and performance is ...
(Date:1/24/2017)... , Jan. 23, 2017 INTRODUCTION ... way from conventional syringes with vials to prefilled ... These modern devices have become preferred devices for ... prefilled syringes has been rising strongly over the ... facilities are now adopting this format for delivering ...
Breaking Medicine Technology: